NEW YORK (GenomeWeb News) – Retroscreen Virology Group today announced it has acquired proteomics firm Activiomics for up to £4.0 million ($6.7 million).

In connection with the deal, Retroscreen is issuing up to £4.0 million of new ordinary shares of £.05 each of its stock, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.